In vivo inhibition of CD44 limits intra-abdominal spread of a human ovarian cancer xenograft in nude mice: a novel role for CD44 in the process of peritoneal implantation - PubMed (original) (raw)

. 1997 Apr 1;57(7):1228-32.

Affiliations

PMID: 9102203

In vivo inhibition of CD44 limits intra-abdominal spread of a human ovarian cancer xenograft in nude mice: a novel role for CD44 in the process of peritoneal implantation

T Strobel et al. Cancer Res. 1997.

Abstract

Ovarian cancer cells frequently metastasize by implanting onto the peritoneal mesothelial lining of the abdominal cavity. Data obtained from in vitro adhesion studies have suggested a possible role for the CD44 molecule in this process. The purpose of the present study was to determine the in vivo role of CD44 in ovarian cancer metastasis by using a nude mouse xenograft model of peritoneal implantation. Three groups of 10 athymic female nude mice each received an i.p. inoculum of 10 x 10(6) cells from a CD44-positive human ovarian cancer cell line (36M2) in the presence of either anti-D144 antibody (Ab; nonreactive IgG1), anti-DF3 Ab (reactive IgG1 Ab that does not inhibit in vitro binding), or neutralizing anti-CD44 Ab (IgG1). The number of peritoneal and diaphragmatic implants at 5 weeks for anti-D144 and anti-DF3-treated groups was 103 +/- 17 and 120 +/- 20, respectively (mean +/- SE; P > 0.2). In contrast, animals treated with anti-CD44 Ab experienced a significant reduction in the number of tumor implants (35 +/- 4; P < 0.002). Anti-CD44 Ab was not inhibitory to the growth of 36M2 cells in vitro and did not inhibit s.c. tumor growth in vivo, suggesting that the observed effect was related to inhibition of peritoneal implantation. These data suggest that the CD44 molecule plays an important in vivo role in ovarian cancer cell implantation and that strategies to inhibit CD44 function may represent a novel approach to limiting the intra-abdominal spread of this highly lethal tumor.

PubMed Disclaimer

Cited by

Mesothelial-to-Mesenchymal Transition and Exosomes in Peritoneal Metastasis of Ovarian Cancer.
Pascual-Antón L, Cardeñes B, Sainz de la Cuesta R, González-Cortijo L, López-Cabrera M, Cabañas C, Sandoval P. Pascual-Antón L, et al. Int J Mol Sci. 2021 Oct 25;22(21):11496. doi: 10.3390/ijms222111496. Int J Mol Sci. 2021. PMID: 34768926 Free PMC article. Review.
Adipocytes: active facilitators in epithelial ovarian cancer progression?
Dai L, Song K, Di W. Dai L, et al. J Ovarian Res. 2020 Sep 23;13(1):115. doi: 10.1186/s13048-020-00718-4. J Ovarian Res. 2020. PMID: 32967712 Free PMC article. Review.
Selectins: An Important Family of Glycan-Binding Cell Adhesion Molecules in Ovarian Cancer.
Hassan AA, Artemenko M, Tang MKS, Wong AST. Hassan AA, et al. Cancers (Basel). 2020 Aug 10;12(8):2238. doi: 10.3390/cancers12082238. Cancers (Basel). 2020. PMID: 32785160 Free PMC article. Review.
Upregulation of mesothelial genes in ovarian carcinoma cells is associated with an unfavorable clinical outcome and the promotion of cancer cell adhesion.
Ojasalu K, Brehm C, Hartung K, Nischak M, Finkernagel F, Rexin P, Nist A, Pavlakis E, Stiewe T, Jansen JM, Wagner U, Gattenlöhner S, Bräuninger A, Müller-Brüsselbach S, Reinartz S, Müller R. Ojasalu K, et al. Mol Oncol. 2020 Sep;14(9):2142-2162. doi: 10.1002/1878-0261.12749. Epub 2020 Jun 25. Mol Oncol. 2020. PMID: 32533757 Free PMC article.
Targeting Cancer Stem Cells to Overcome Therapy Resistance in Ovarian Cancer.
Muñoz-Galván S, Carnero A. Muñoz-Galván S, et al. Cells. 2020 Jun 4;9(6):1402. doi: 10.3390/cells9061402. Cells. 2020. PMID: 32512891 Free PMC article. Review.

In vivo inhibition of CD44 limits intra-abdominal spread of a human ovarian cancer xenograft in nude mice: a novel role for CD44 in the process of peritoneal implantation - PubMed (original) (raw)